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REPLY
We would like to thank Karamanoukian, Donias and Bergsland for
their remarks regarding our randomized trial of percutaneous
coronary intervention (PCI) versus coronary artery bypass graft
(CABG) in patients with medically refractory myocardial ischemia
and risk factors for early mortality with CABG. They raise two
specific issues about our surgeons’ CABG methods: 1) variability
in myocardial protection, and 2) use of “beating heart” or “off-
pump” techniques.
Our trial was an attempt to answer a real-world clinical question
that often seems to arise on nights and weekends: “What is the best
means of revascularizing this high-risk patient who desperately
needs more myocardial blood flow?” To make the trial clinically
relevant in an era when techniques are evolving and strong
differences of opinion exist, we settled on a “strategy” study. That
is, both our surgeons and interventionists could use whatever tools
and methods they believed would yield the best long-term out-
come for their individual patients. Accordingly, the means of
myocardial protection varied from center to center and even
operator to operator. We obtained prospective data regarding such
issues as antegrade versus retrograde, cold versus warm and
crystalloid versus blood, specifically so that we could look at both
temporal and spatial variations in technique and attempt to
determine what, if any, influence those variations had on outcome.
From the overall perspective, an in-hospital mortality of 4% for the
oldest (mean age 67 years; 5 years older than any other
revascularization trial), and sickest (mean left ventricular ejection
fraction  0.45; 0.12 lower than any other revascularization trial
and1/3 patients within seven days of a myocardial infarction and
1/3 patients with prior CABG: both high-risk exclusions from
previous trials), suggests that we had excellent myocardial protec-
tion.
Regarding the issue of “off-pump,” although Karamanoukian
and colleagues state that 1995 is when the method was popular-
ized, their citation is dated 1997, and most of their references are
electronic abstracts, dated 2000 and 2001, after AWESOME
completed enrollment. This timing explains why we did not even
collect data on the use of this method. Several of our study
surgeons are among the planners of a proposed Veterans Affairs
cooperative study, which we are told would randomly allocate
patients between conventional and off-pump surgery. We look
forward to that type of data. In the meantime, we must continue
to make the difficult and often nocturnal decisions, in part,
influenced by the awareness of which techniques each of us is most
comfortable using.
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Perpetuation of the Myth of the Q-Wave
Versus the Non–Q-Wave Myocardial Infarction
In a recently published study, Furman et al. (1) perpetuate the
myth that the non–Q-wave myocardial infarction (MI) is a
“distinctive pathophysiological entity from non–Q-wave MI
(NQWMI).” The results and conclusions of that study deserve
careful scrutiny.
The classification of Q-wave versus NQWMI was based on the
presence or absence of Q waves 24 h after hospital admission. It
has been documented that at least 10% of patients will develop Q
waves between 3 to 11 days after MI (2). This error could well
affect the results and conclusion. Even though the same definition
was used throughout the study, it is not clear whether the potential
error was unchanged throughout the study.
In addition, limiting the electrocardiogram (ECG) definition of
Q-wave MI (QWMI) to a Q-wave of 0.04 s and an amplitude
25% of the R-wave in that lead (in addition to evolutionary ST-
and T-wave changes) is a perpetuation of an older and now
discarded definition of the pathologic Q-wave. In a recent con-
sensus document (3) the ECG criteria for establishing an MI are
“any Q-wave in leads V1 through V3, Q-wave 30 msec in leads
II, III, aVL, V4, V5 or V6 (the Q-wave changes must be present in
any two continuous leads), and be 1 mm in depth.” In addition, it
was noted that criteria for Q-wave depth requires more research.
Inevitably, many infarcts presenting with significant wide but
shallow pathologic Q waves would be erroneously lumped by
Furman et al. (1) in the NQWMI category. Thus, the criteria
selected in the Furman et al. (1) study would tend to overestimate
the number of patients with NQWMI. These problems in classi-
fication illustrate one of the difficulties in attempting to classify
patients as Q-wave versus NQWMI.
Furman et al. (1) quote the criteria for an adequate study as
outlined in our report (4) in this Journal in 1997 and they claim
they corrected for the variables we listed. However, they failed to
correct for one of the most important variables, and this omission
can alter the results and conclusions. They recognized only the
negative deflection in the first 40-ms vectors, or classic Q-wave,
completely overlooking other depolarization abnormalities or “Q-
wave equivalents” that have been well documented to correlate
with MI. For example, ECGs that present the onset of tall R waves
in leads V1 and V2 representing the “Q-wave” of posterior
infarction would be classified as an NQWMI by Furman et al. (1).
This error has plagued most studies in this field and is worth
emphasizing. We quote from our previous publication in the
Journal: “The process of infarction alters depolarization by a
number of mechanisms, e.g., dispersion, slow conduction and
localized block. These forces change the surface QRS in a number
of ways: to suppose that they only cause negative deflections, or Q
waves, is electrocardiographically naive. It is equally naive to
confine attention to the initial 40 msec vectors since at least 8% to
10% of all infarcts involve the basal myocardium, which is
depolarized during the middle or terminal vectors of the QRS. A
tall R in the right precordium and localized R-wave diminution in
the mid precordium are two obvious and accepted ‘Q-wave
equivalents’ but there are others. QRS alterations correlated with
infarction in a number of studies include R/S changes, acute
frontal-plane right axis deviation, new left axis deviation, low
voltage and QRS notching, precordial QRS notching, initial and
terminal QRS notching, high-frequency notching in orthogonal
leads and abnormally narrow precordial R waves. . . . Summing up
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findings of the studies listed above in quantitative terms, it is
conservative to estimate that approximately half of all infarcts
without Q waves will manifest Q-wave–equivalent distortions of
depolarization. . . . The only scientifically valid basis for compari-
son would be ‘depolarization abnormality’ versus ‘repolarization
abnormality only.’ Thus, even if only a third of the NQWMI in
fact belong in the QWMI category—a modest assumption—the
differences alleged in this study could be markedly altered” (4).
Every pathologic study in the last 20 or more years has
demonstrated that the pathology of the two types of infarct is
identical (5,6). Most recently Wu et al. (7) published a study
correlating ECG with pathology; like all others, the researchers
found that nontransmural infarcts generated Q waves 50% of the
time. It is difficult to imagine the NQWMI to be a “distinct
pathophysiologic entity” when the cellular pathology is exactly the
same as the QWMI.
The investigators (1) erroneously reported that Edlavitch et al.
(8) provided data that support the conclusion of the present study
that an increase in the incidence of NQWMI and QWMI
occurred over a period of time. In that study, which preceded the
thrombolytic area and extended from 1970 to 1980, the attack rate
for QWMI did not change significantly between 1970 and 1980,
but the attack rate for NQWMI decreased significantly during this
same period.
Finally, the preoccupation with Q-wave versus NQWMI
should be abandoned in favor of truly significant observations that
have a well-documented bearing on acute as well as long-term
prognosis, such as evaluation of infarct size, left ventricular ejection
fraction, New York Heart Association functional class, coronary
anatomy and symptoms. These observations will be able to guide
the cardiologist in the choice of therapy and prognosis. The Q
versus non-Q distinction contributes nothing of pragmatic thera-
peutic significance, as is demonstrated by the fact that patients
with NQWMI randomly assigned to an invasive or noninvasive or
conservative management resulted in similar outcome (9).
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REPLY
In their letter to the editor, Phibbs and Marcus essentially reiterate
what they wrote in their 1999 editorial (1) in the Journal of the
American College of Cardiology. Indeed, the research that resulted in
our article (2) was initiated as a result of the publication of the
editorial. We agree that classifying myocardial infarction (MI) into
Q-wave and non–Q-wave is not ideal and should be replaced with
ST-segment elevation MI and non–ST-segment elevation MI.
However, because the distinction between Q-wave and non–Q-
wave MI has been standard in the literature, it is necessary to use
it to ascertain past trends in incidence and short-term and
long-term mortality rates. We agree with Phibbs and Marcus’s
contention that electrocardiograph (ECG) changes in MI correlate
poorly with the extent of transmural myocardial necrosis. We also
agree that the definition of Q-wave we used is an “older”
definition. However, as our initial study period began in 1975, we
are forced to use the original definition of Q-wave MI. We
consider that the fact that our study originated in 1975, and that
our definition was consistent over 22 years, is one of our study’s
strengths.
We disagree with Phibbs and Marcus that the pathology of
Q-wave and non–Q-wave MI is the same. The essential role of the
extent and pathology of coronary atherosclerosis is a critical
determinant as to why certain patients develop unstable angina,
non–Q-wave MI, or Q-wave MI. The simple fact remains that
patients with initial non–Q-wave MI, including some patients
with transmural infarction and others with “Q-wave equivalents,”
have consistently over time shown a worse long-term prognosis
than survivors of initial Q-wave MI and until most recently no
change in hospital mortality. These distinctions are of paramount
importance and strongly suggest that separate pathophysiologic
processes may be partially responsible for these differences in
outcomes.
The TACTICS-TIMI study (3) demonstrated that, in patients
with unstable angina and non–ST-segment elevation MI receiving
a glycoprotein IIb-IIIa antagonist, those who underwent an early
invasive strategy, as compared with those who underwent an early
conservative strategy, had a significant decrease in adverse cardiac
events. The fact that, until recently, there has been no proven
effective therapy for the reduction of mortality in patients with
non–Q-wave MI further suggests that the pathophysiologic pro-
cesses leading to non–Q-wave MI are distinct from Q-wave MI.
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